Skip to main content
. 2023 Feb 27;80(4):377–387. doi: 10.1001/jamaneurol.2023.0001

Table. Participants’ Demographic and Neuropsychological Featuresa.

Characteristic Mean (SD) P value
VAC-FTD (n = 17) NVA-FTD (n = 51) HC (n = 51)
Clinical diagnosis, No. (%)
svPPA 8 (47.1) 24 (47.1) NA NA
bvFTD 3 (17.6) 9 (17.6) NA NA
nfvPPA 2 (11.8) 6 (11.8) NA NA
PSP-RS 2 (11.8) 6 (11.8) NA NA
CBS 1 (5.9) 3 (5.9) NA NA
ALS 1 (5.9) 3 (5.9) NA NA
Age at MRI scan, y 65 (9.7) 64.8 (7) 64.5 (7.2) >.99
Sex, No. (%)
Male 7 (41.1) 26 (51.0) 26 (51.0) .76
Female 10 (58.8) 25 (49.0) 25 (49.0)
Handedness, No. (%)
Right 14 (82.4) 42 (82.4) 43 (84.3) .96
Left 3 (17.6) 9 (17.6) 8 (15.7)
Education, yb 16.1 (4.7) 16.6 (2.1) 16.7 (2) .77
Race and ethnicity, No. (%)
Asian 0 1 (2.0) 8 (15.7) NA
Hispanic 0 1 (2.0) 0
White 17 (100) 49 (96.1) 38 (74.5)
Not reported 0 0 5 (9.8)
CDR-SB (maximum, 18) 4.6 (2.8) 4.6 (3.1) 0 (0) .94
Mini-Mental State Examination score (maximum, 30)c 27.1 (2.6) 22.7 (6.2) NA .004
Boston Naming Test (maximum, 15)c 10.4 (4.5) 8.4 (5.5) NA .17
Phonemic fluency (D words/1 min)c 7.4 (4.2) 7.3 (4.8) NA .52
Semantic fluency (animals/1 min) 10.9 (4.4) 9.8 (6) NA .46
Modified Rey-O copy (maximum, 17)c 15.3 (1.2) 14.6 (2.5) NA .53
CVLT SF
4 Trials (maximum, 36) 22.1 (5.3) 17.6 (7.7) NA .01
30-s Recall (maximum, 9) 5.6 (2) 3.8 (2.8) NA .01
10-min Recall (maximum, 9)c 4.4 (2.9) 3.1 (3) NA .14
Recognition hitsc 7.4 (1.5) 7.1 (2.3) NA >.99
Modified Rey-O Figure
10-min Delay (maximum, 17) 9.9 (3.4) 6.4 (4.7) NA .002
Recognition (yes/no) 0.8 (0.4) 0.8 (0.4) NA .72
Digit span backwardc 4.4 (1.2) 4.1 (1.2) NA .35
Modified trails
Correct lines/1 min 22.7 (15.4) 19.3 (12.3) NA .42
Errorsc 1.1 (1.4) 1 (1.3) NA .81
Design fluency (correct designs/1 min) 8.2 (3.7) 6.5 (3.1) NA .14
NPI subscale responses, yes, No. (%)
Delusions 2 (12) 5 (10) NA .82
Hallucinations 1 (6) 3 (6) NA >.99
Agitation 8 (47) 22 (43) NA .78
Elation 3 (18) 22 (43) NA .06
Anxiety 8 (47) 23 (45) NA .89
Depression 6 (35) 24 (47) NA .40
Irritability 8 (47) 25 (49) NA .89
Motor disturbance 8 (47) 31 (61) NA .32
Nighttime behaviors 6 (35) 31 (61) NA .07
Appetite 10 (59) 35 (69) NA .46
Apathy 10 (59) 38 (75) NA .22
Disinhibition 9 (53) 38 (75) NA .10

Abbreviations: ALS, amyotrophic lateral sclerosis; bvFTD, behavioral variant of frontotemporal dementia; CBS, corticobasal syndrome; CDR-SB, Clinical Dementia Rating scale sum of boxes; CVLT SF, California Verbal Learning Test Short Form; HC, healthy controls; MRI, magnetic resonance image; NA, not applicable; nfvPPA, nonfluent variant of primary progressive aphasia; NPI, Neuropsychiatric Inventory; NVA-FTD, frontotemporal dementia spectrum disease without emergence of visual artistic creativity; PSP-RS progressive supranuclear palsy with Richardson syndrome; svPPA, semantic variant of primary progressive aphasia; VAC-FTD, frontotemporal dementia spectrum disease and emergence of visual artistic creativity.

a

All cognitive measures were available for at least 80% of participants in each group. NPI measures were available for all participants.

b

Kruskal-Wallis test was used.

c

Mann-Whitney test was used.